Efficacy and safety of pleurodesis for lung cancer patients with interstitial lung disease.

ABSTRACT:

Background

Managing malignant pleural effusion (MPE) with pleurodesis is essential for symptom relief and minimizing the need for repeated thoracentesis. Interstitial lung disease (ILD) is one of the most common complications associated with advanced lung cancer. However, the efficacy and safety of pleurodesis for MPE secondary to lung cancer with ILD remains unclear. This study aimed to evaluate the efficacy and safety of pleurodesis in this population.

Methods

This study was a single-center retrospective analysis. The cases of pleurodesis in patients with MPE secondary to lung cancer complicated with ILD at Nippon Medical School Hospital (Tokyo, Japan) between January 2010 and December 2022 were included.

Results

Of the 26 lung cancer patients with ILD who underwent

SUBMITTER: Iso H 

PROVIDER: S-EPMC11898400 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature